Spruce Biosciences BLA filing for rare disease drug on track for 2026
Go back to Spruce Biosciences BLA filing for rare disease drug on track for 2026| (NASDAQ: SPRB) | Delayed: 59.09 +1.16 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.93 | 52 Week High | $ | |||
| Open | $57.39 | 52 Week Low | $ | |||
| Day High | $60.51 | P/E | N/A | |||
| Day Low | $56.60 | EPS | $ | |||
| Volume | 186,655 | |||||

